Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
Sponsor: Asociación para Evitar la Ceguera en México
Summary
The goal of this clinical study is to assess the safety of multiple intracameral injections of EO2002 with and without topical Ripasudil.
Official title: Phase 1, Multiple Dose, Open-Label Study to Assess the Safety and Tolerability of EO2002 Intracameral Injections With or Without Topical Ripasudil in the Treatment of Corneal Edema
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2022-11-08
Completion Date
2025-12-09
Last Updated
2025-12-08
Healthy Volunteers
No
Conditions
Interventions
EO2002
Intracameral injection of magnetic human corneal endothelial cells (EO2002)
Ripasudil
Daily use of Ripasudil drops
Locations (1)
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City, Mexico